PD 237 (Zarontin 250 mg)
Generic Name: ethosuximide
Pill imprint PD 237 has been identified as Zarontin 250 mg.
Zarontin is used in the treatment of seizures and belongs to the drug class succinimide anticonvulsants. FDA has not classified the drug for risk during pregnancy. Zarontin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ethosuximide
- Imprint:
- PD 237
- Strength:
- 250 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Succinimide anticonvulsants
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Parke-Davis
- National Drug Code (NDC):
- 00071-0237
- Inactive Ingredients:
- polyethylene glycol 400
D&C Yellow No. 10
FD&C Red No. 3
gelatin
glycerin
sorbitol
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-2250 | Greenstone LLC |
Note: Inactive ingredients may vary.
More about Zarontin (ethosuximide)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
